|
Journal of Child and Adolescent Psychopharmacology
Current Prescribing Patterns in Outpatient Child and Adolescent Psychiatric Practice in Central New York
To cite this article:
Jud A. Staller, Michael J. Wade, Molly Baker.
Journal of Child and Adolescent Psychopharmacology.
2005,
15(1): 57-61.
doi:10.1089/cap.2005.15.57.
Published in Volume: 15 Issue 1: March 1, 2005
Jud A. Staller, M.D.Department of Psychiatry SUNY Upstate Medical University, Syracuse, New York. Michael J. Wade, M.S.Department of Psychiatry SUNY Upstate Medical University, Syracuse, New York. Molly Baker, B.A.Department of Psychiatry SUNY Upstate Medical University, Syracuse, New York. Objective: The aim of this study was to evaluate current prescribing patterns of outpatient child psychiatrists in central New York. Methods: Data were drawn from all active files of 1- to 18-year-olds (n = 1292) at eight outpatient treatment locations in central New York on one day in 2002. Age, race, gender, diagnoses, current medications, and doses were recorded. Data was tabulated and analyzed to discern prescribing frequencies and patterns. Results: 74% (956 of 1292) of all patients received psychotropic medication, and 50% of these patients (478 of 956) received two or more medications. The most commonly prescribed medications were stimulants, antidepressants, antipsychotics, alpha-agonists, and "mood stabilizer" anticonvulsants. The most frequent diagnoses were attention-deficit/hyperactivity disorder, other disruptive behavior disorders, anxiety disorders, and depressive disorders. Of those youths who received an antipsychotic medication, 77% did not have a diagnosis of a psychotic disorder. Conclusions: Psychotropic prescribing frequency in outpatient child psychiatry continues to increase, with a substantial majority of youth in psychiatric treatment receiving medication. Stimulants, antidepressants, and antipsychotics have led the way, as in prior studies. Co-prescribing represents a substantial, and growing, proportion of prescribing practice. Antipsychotics are frequently prescribed for nonpsychotic conditions.  This paper was cited by:Psychotropic Medication Utilization at a Group-Home Residential Facility for Children and Adolescents Michael L. Handwerk, Gail L. Smith, Ronald W. Thompson, Douglas F. Spellman, Daniel L. Daly Journal of Child and Adolescent Psychopharmacology. Oct 2008, Vol. 18, No. 5: 517-525 Abstract | Full Text PDF | Reprints & PermissionsUse of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay D. L. Pogge, K. Young, B. Insalaco, P. D. Harvey International Journal of Clinical Practice. Jul 2007, Vol. 61, No. 6: 896-902 CrossRef CMAP ADHD AND COMORBID AGGRESSION ALGORITHM Steven R. Pliszka, M. Lynn Crismon, Carroll W. Hughes, C. Keith Conners, Graham J. Emslie, Peter S. Jensen, James T. McCracken, James M. Swanson, Molly Lopez Journal of the American Academy of Child & Adolescent Psychiatry. Feb 2007, Vol. 46, No. 1: 2-3 CrossRef The Effect of Long-Term Antipsychotic Treatment on Prolactin Jud Staller Journal of Child and Adolescent Psychopharmacology. Jun 2006, Vol. 16, No. 3: 317-326 Abstract | Full Text PDF | Reprints & PermissionsEndocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and Adolescents CHRISTOPH U. CORRELL, HAROLD E. CARLSON Journal of the American Academy of Child & Adolescent Psychiatry. Jun 2006, Vol. PAP CrossRef
|
|